-
Weekly Companion Animal News: March 9, 2026
Merck receives FDA approval for NUMELVI for dogs Merck reports NUMELVI is the only second-generation Janus kinase (JAK) inhibitor...
-
Weekly Companion Animal News: March 2, 2026
Gallant, MWI to create ultra-low temperature cold chain for stem cell therapies Gallant, developer of off-the-shelf stem cell therapies...
-
Weekly Companion Animal News: February 23, 2026
Covetrus and MWI Animal Health to merge Cencora and Covetrus entered into a definitive agreement under which Covetrus and...
-
Covetrus, MWI Animal Health to Merge in Deal Valued at $3.5 Billion
Covetrus and MWI Animal Health will merge, creating a combined animal health platform, according to an announcement from the...
-
Weekly Companion Animal News: February 16, 2026
AB Science receives FDA clearance for Masivet for canine mast cell tumors AB Science SA announced that the FDA...
-
Weekly Companion Animal News: February 9, 2026
Antiviral therapy found effective in treating cats with FIP Colorado State University veterinarians tested an antiviral therapy – molnupiravir...
-
Weekly Companion Animal News: February 2, 2026
New SoundByte: Bionet The new O’Pet Curv is a compact, cloud-connected wireless monitoring system that enables veterinarians to track...
-
Weekly Companion Animal News: January 26, 2026
IDEXX expands panel to include canine mast cell tumor IDEXX announced the expansion of its IDEXX Cancer Dx Panel...
-
Weekly Companion Animal News: January 19, 2026
HT VET launches VISTA iQ cancer detection technology for dogs HT VET has launched the VISTA iQ, the next...
-
Weekly Companion Animal News: January 12, 2026
New Soundbyte: Felycin®-CA1 Felycin®-CA1 from PRN® Pharmacal is conditionally approved by the FDA for the management of ventricular hypertrophy...





